Morany, Adi
Lavon, Karin
Gomez Bardon, Ricardo
Kovarovic, Brandon
Hamdan, Ashraf
Bluestein, Danny
Haj-Ali, Rami
Funding for this research was provided by:
National Institutes of Health (U01- EB026414)
Article History
Received: 7 August 2022
Accepted: 28 December 2022
First Online: 10 February 2023
Declarations
:
: Karin Lavon is an employee of Edwards Lifesciences Ltd. Author Danny Bluestein has an equity interest in PolyNova Cardiovascular Inc. All other authors state that they have no financial and/or personal relationships with other people or organizations that could inappropriately influence or bias the publication of this study.